Nityanand Jain

Mr. Nityanand Jain

Riga Stradins university, Institute of Anatomy and Anthropology, Riga, Latvia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2023 in Oral Diseases
Verified
Journal Article
Closed access
Nityanand JainNityanand Jain
Nityanand Jain
UDUpasna Dutt
Upasna Dutt
IRIgor Radenkov
Igor Radenkov
SJShivani Jain
Shivani Jain

19 September 2022 in Virus Research
Verified
Journal Article
Open access
ELEdouard Lansiaux
Edouard Lansiaux
Nityanand JainNityanand Jain
Nityanand Jain
SLSniedze Laivacuma
Sniedze Laivacuma
ARAigars Reinis
Aigars Reinis
First described in 1958, the human monkeypox virus (hMPXV) is a neglected zoonotic pathogen closely associated with the smallpox virus. The virus usually spreads via close contact with the infected animal or human and has been endemic mostly in parts of the African continent. However, with the recent increase in trade, tourism, and travel, the virus has caused outbreaks in countries outside Africa. The recent outbreak in 2022 has been puzzling given the lack of epidemiological connection and the possible sexual transmission of the virus. Furthermore, there is limited understanding of the structural and pathogenetic mechanisms that are employed by the virus to invade the host cells. Henceforth, it is critical to understand the working apparatus governing the viral-immune interactions to develop effective therapeutical and prophylactic modalities. Hence, in the present short communication, we summarize the previously reported research findings regarding the virology of the human monkeypox virus.

1 January 2022 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
Nityanand JainNityanand Jain
Nityanand Jain
SPSakshi Prasad
Sakshi Prasad
ZCZsófia Csenge Czárth
Zsófia Csenge Czárth
SCSwarali Yatin Chodnekar
Swarali Yatin Chodnekar
SMSrinithi Mohan
Srinithi Mohan
ARAigars Reinis
Aigars Reinis
War refugees and veterans have been known to frequently develop neuropsychiatric conditions including depression, post-traumatic stress disorder (PTSD), and anxiety disorders that tend to leave a long-lasting scar and impact their emotional response system. The shear stress, trauma, and mental breakdown from overnight displacement, family separation, and killing of friends and families cannot be described enough. Victims often require years of mental health support as they struggle with sleep difficulties, recurring memories, anxiety, grief, and anger. Everyone develops their coping mechanism which can involve dependence and long-term addiction to alcohol, drugs, violence, or gambling. The high prevalence of mental health disorders during and after the war indicates an undeniable necessity for screening those in need of treatment. For medical health professionals, it is crucial to identify such vulnerable groups who are prone to developing neuropsychiatric morbidities and associated risk factors. It is pivotal to develop and deploy effective and affordable multi-sectoral collaborative care models and therapy, which primarily depends upon family and primary care physicians in the conflict zones. Herein, we provide a brief overview regarding the identification and management of vulnerable populations, alongside discussing the challenges and possible solutions to the same.

11 July 2023 in Gut Microbes
Verified
Journal Article
Open access
Nityanand JainNityanand Jain
Nityanand Jain
Tungki Pratama UmarTungki Pratama Umar
Tungki Pratama Umar
AFAnne-Fleur Fahner
Anne-Fleur Fahner
VĢValdis Ģībietis
Valdis Ģībietis
Clostridioides difficile infections (CDI) are a leading cause of healthcare-associated infections with a high relapse rate. Current treatment guidelines recommend fidaxomicin as the primary therapy for initial CDI episodes and suggest alternative approaches for recurrent episodes, including fecal microbiota transplantation (FMT). This paper explores the recent approval of Vowst, a novel oral FMT drug, by the United States Food and Drug Administration (FDA) as a prophylactic therapy to prevent recurrent CDIs. Vowst comprises a formulation of live fecal microbiota spores and works by reestablishing the disrupted gut microbiota, limiting C. difficile spore germination, and promoting microbiome repair. Furthermore, this paper will discuss the product’s approval journey and the uncertainties regarding its efficacy in CDI patients beyond the ones who participated in the clinical trials, pharmacovigilance, cost estimates, and the need for a more stringent donor screening process. Overall, Vowst’s approval marks a significant step forward in the prevention of recurrent CDI infections with various beneficial implications for future gastroenterology.

15 December 2022 in New Microbes and New Infections
Verified
Journal Article
Open access
Nityanand JainNityanand Jain
Nityanand Jain
ELEdouard Lansiaux
Edouard Lansiaux
ARAigars Reinis
Aigars Reinis

1 January 2023 in AIMS Public Health
Verified
Journal Article
Open access
PDF file
Nityanand JainNityanand Jain
Nityanand Jain
IKIslam Kourampi
Islam Kourampi
Tungki Pratama UmarTungki Pratama Umar
Tungki Pratama Umar
ZAZahra Rose Almansoor
Zahra Rose Almansoor
AAAyush Anand
Ayush Anand
ARAigars Reinis
Aigars Reinis
In November 2022, the global population had officially crossed eight billion. It has long been recognized that socioeconomic or health-related problems in the community always accompany an uncontrolled population expansion. International calls have been made regarding lack of universal health coverage, an insufficient supply of healthcare providers, the burden of noncommunicable disease, population aging and the difficulty in obtaining safe drinking water and food. The present health policy paper discusses how to conquer these crowded world issues, including (1) promoting government and international organization participation in providing appropriate infrastructure, funding and distribution to assist people's health and well-being; (2) shifting health program towards a more preventive approach and (3) reducing inequalities, particularly for the marginalized, isolated and underrepresented population. These fundamental principles of health policy delivery as a response to an increasingly crowded world and its challenges are crucial for reducing the burden associated with excessive healthcare costs, decreased productivity and deteriorating environmental quality.